Forte Biosciences, Inc.FBRXNASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank90
3Y CAGR+56.6%
5Y CAGR+30.4%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+56.6%/yr
vs -31.5%/yr prior
5Y CAGR
+30.4%/yr
Recent acceleration
Acceleration
+88.2pp
Accelerating
Percentile
P90
Near historical high
vs 5Y Ago
3.8x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $53.38M | +46.0% |
| 2024 | $36.56M | +12.6% |
| 2023 | $32.48M | +133.7% |
| 2022 | $13.90M | -35.3% |
| 2021 | $21.49M | +51.6% |
| 2020 | $14.17M | +249.6% |
| 2019 | $4.05M | -93.6% |
| 2018 | $63.26M | +69.3% |
| 2017 | $37.38M | +18.7% |
| 2016 | $31.48M | - |